Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Nephrocare Health Services Limited (NEPHROPLUS)
Market Closed
10 Aug, 22:00
MSE
All
(2)
IN
(2)
MSE
Primary
XNSE
₹
696.
15
+1.95
+0.2809%
₹
66.2B
Market Cap
-
P/E Ratio
-
Div Yield
9,891
Volume
-
Eps
₹
694.2
Previous Close
Watching
Watch
Add Transaction
Day Range
675.75
709.15
Year Range
445
767.95
Want to track
NEPHROPLUS
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
Nephrocare Health Services Limited (NEPHROPLUS) Statistics
Valuation metrics
Market Cap
66.2B
Enterprise value
62.68B
Trailing P/E (ttm)
81.58
Forward P/E
32.29
PEG ratio
32.29
Price/Sales (ttm)
6.62
Price/Book (mrq)
1.68
Enterprise Value/Revenue
6.28
Enterprise Value/EBITDA
27.61
Overview
Shares outstanding
100.34M
Float
28.37M
Shares short
-
% Held by insiders
0.55%
% Held by institutions
0.32%
Average volume (10 days)
32.75K
Average volume (90 days)
28.02K
Price summary
52-Week low
445
52-Week high
767.95
Beta
-
50-Day moving average
560.12
200-Day moving average
539.05
Financials
Fiscal year
Fiscal year ends
31 Mar 2026
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.08%
Operating margin
0.11%
Operational effectiveness
Return on assets
0.07%
Return on equity
0.09%
Income Statement
Revenue (ttm)
9.99B
Revenue per share (ttm)
110.23
Quarterly revenue growth (yoy)
0.21%
Gross profit (ttm)
4.08B
EBITDA
2.31B
Net income to common (ttm)
768.4M
Diluted EPS (ttm)
8.08
Quarterly earnings growth (yoy)
0.22%
Balance Sheet
Total cash (mrq)
4.26B
Total cash per share (mrq)
42.47
Total debt (mrq)
797.07M
Total Debt/Equity (mrq)
7.14
Current ratio (mrq)
2.8%
Book value per share (mrq)
391.25
Cash Flow
Cash flow statement
2.33B
Levered free cash flow (LFCF)
897.25M